| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.064 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |